Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MabVax Therapeutics Holdings Inc (OTCQB:MBVX)

0.54
Delayed Data
As of Feb 05
 -0.0199 / -3.55%
Today’s Change
0.49
Today|||52-Week Range
4.94
-21.17%
Year-to-Date
No recent news for MabVax Therapeutics Holdings Inc.

Today’s Trading

Previous close0.56
Today’s open0.56
Day’s range0.52 - 0.56
Volume9,070
Average volume (3 months)83,343
Market cap$15.3M
Dividend yield--
Data as of 3:57pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-1.60%
Earnings growth (this year)--
Earnings growth (next 5 years)+54.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales6.44
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$314.2K
Annual profit (last year)-$7.9M
Net profit margin-2,520.20%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John David Hansen
VP-Pharmaceutical Development &
Operations
Paul W. Maffuid
Corporate headquarters
San Diego, California

Forecasts

Partner Offers